Please login to the form below
Europe
This page shows the latest Europe news and features for those working in and with pharma, biotech and healthcare.
Pfizer, BioNTech temporarily slow down shipments of COVID-19 vaccine to EU
The Pfizer/BioNTech mRNA-based vaccine has received conditional or emergency approval in the US, UK, Europe and other countries.
Latest news
-
Amgen strikes $240m autoimmune deal with Evoq Therapeutics
available in Europe and approved ahead of a likely US launch in 2023.
-
New dosing option for AZ’s Imfinzi approved in the EU and UK
We are pleased to offer a four-week dosing option to lung cancer patients in Europe to meet an urgent need and help enable continuity of care during the pandemic,” said
-
AZ seeks EU approval for its Oxford University-partnered COVID-19 vaccine
According to Politico, the UK is leading the charge in Europe in terms of the number of vaccinations it has already administered.
-
BioNTech boosts COVID-19 vaccine capacity and aims to deliver 2 billion doses in 2021
Company will also publish data on vaccine's efficacy against new variants soon
-
Roche’s flu pill Xofluza gains EU approval
Xofluza offers patients the first novel mechanism of action for treating influenza approved in Europe in almost 20 years.
More from news
Approximately 75 fully matching, plus 3,199 partially matching documents found.
Latest Intelligence
-
The search for effective drug treatments for COVID-19
The results from the NIAID’s ACTT-1 trial, which was conducted primarily in the United States and Europe, found that remdesivir SOC significantly shortened time to recovery, provided greater clinical ... Our manufacturing network now includes more than
-
The Brexit clock is counting down and time is running out
Consider future business trips. Pharma businesses will be used to their European colleagues coming across to the UK and British nationals travelling to Europe – for example, to collaborate on projects for
-
Treatment and prevention of cardiovascular disease
The annual cost of cardiovascular disease in 2019 was officially estimated at $351bn in the US and 210bn a year in Europe. ... Epeleuton is currently being studied in a phase 2b multinational trial in the US and Europe, with results expected before the
-
Rebranding in an evolving world
hospital medicines in Europe. ... It also brings a highly experienced team, with significant commercial and medical knowledge, as well as established relationships with healthcare professionals across Europe – something we are very much looking to
-
Unlocking the potential of precision medicine in oncology
More specifically, through our ORACULUM studies, we are using AI to analyse patient-level data that is collected through electronic health records across numerous countries in Europe, the Middle East and
More from intelligence
Approximately 20 fully matching, plus 392 partially matching documents found.
Latest appointments
-
Nucleus Global announces a trio of promotions
Most recently, he served as Nucleus Global’s regional director, Europe, a role in which he led eight agencies.
-
New faces at HCA, P\S\L Group and Health Unlimited
Sansum is currently director of scientific and medical communications at Publicis Health, and Taylor is director of Cello Health Communications in Europe.
-
W2O taps Tom Richards as creative leader of 21GRAMS
W2O, a leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector, employs over 1, 300 people in 18 offices across the US and in Europe.
-
Syneos Health appoints trio of senior hires
Ian Dorrian (pictured above), president of EU communications. Dorrian is leading Syneos Health Communications in Europe and brings more than 20 years of agency experience spanning independent firms, major holding companies,
-
Azafaros expands executive team with three senior hires
While at Sanofi, she served as head of rare diseases, Central and Eastern Europe – in this role, she led all commercial activities for rare disease-related programmes in those regions. ... Before this, she held the position of head of business
More from appointments
Approximately 3 fully matching, plus 286 partially matching documents found.
Latest from PMHub
-
Mistrust in medical research: a patient perspective
Suddenly people were comparing the length of approval processes in the UK, Europe, and the US.
-
The 7 biggest risks to e-detailing success
For the US, Europe and Japan, please call Andy Holgate on 44 1530 562300 or email Andy Holgate.
-
Ashfield to host webinar on Patient Support Programmes on Tuesday 10 October
Nagore Fernandez, Ashfield’s Head of Patient Services for Europe, shares what it takes to launch and measure a successful patient support programme.
-
It's out - so what?
Europe’s Beating Cancer Plan is the first clear initiative from this Commission and the largest political group in the European Parliament – the European People’s Party (EPP) – has been championing ... With COVID-19 and lessons learnt, it also
-
OPEN VIE and Pharmerit Bring the Best of Both Worlds to Virtual ISPOR Europe 2020
Join OPEN VIE and Pharmerit – an OPEN Health Company at the ISPOR European Virtual Conference from 16-19 November 2020 to see how we are shaping the healthcare industry with innovative research methods and world-class communications. At this
More from PMHub
Approximately 8 fully matching, plus 259 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
-
Medical Editor
-
Competitive
-
Healthcare Account Director
-
Competitive
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Pfizer introduces new logo in a ‘shift from commerce to science’
- New study identifies drugs that are safe to use in COVID-19 treatment
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Life Healthcare Communications
Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
